2019 Cannabis Business Award's
Publication of the Year |
REGISTER FOR THE NEXT MEETING
MAY 24, 2023 SPECIAL LEGISLATIVE UPDATE THE "FLORIDA MEDICAL CANNABIS
PHYSICIAN GROUP" (FMCPG) FOR ALL "MEDICAL MARIJUANA DOCTORS"
AND "MMTC DIRECTORS ONLY "
SIGN UP TODAY
TOPICS TO BE DISCUSSED UPDATE FROM TALLAHASSEE ON TELEHEALTH BILL FOR CANNABIS PATIENTS PASSED BY THE HOUSE AND SENATE, NOW WAITNG FOR THE GOVERNOR
UPDATE FROM TALLAHASSEE ON THE HEMP BILL PROTECTING YOUR MEDICAL CANNABIS PRACTICE QUESTIONS FROM PHYSICIANS
HOW TO BEST ANSWER YOUR PATIENT QUESTIONS CLICK HERE TO REGISTER FOR THE
MAY 24 MEETING |
JOIN CANNABIS NEWS FLORIDA AND
FLORIDA MEDICAL CANNABIS PHYSICIANS GROUP AT FMCCE ON JUNE 2 - 4 IN ORLANDO
ONLY TWO WEEKS TO GO |
ASK ABOUT FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP 50% DISCOUNT
Email me at: charles@cannabisnewsflorida.com phone: 954-605-4785 |
NEWS FROM THE PAST WEEK RELATING TO THE BUSINESS OF CANNABIS IN FLORIDA Click on Company Logo to be Transferred to Web Site |
TRULIEVE REPORTS FIRST QUARTER 2023 RESULTS MARKING PROGRESS ON CASH OBJECTIVES
Record 4/20 results with traffic, customers served, and units sold up 10%, 11%, and 9%, respectively, year over year
Cost reduction initiatives deliver $24 million decrease in SG&A expenses
Industry leading U.S. retail network of 184 dispensaries, up 14% year over year, supported by over 4 million square feet of cultivation and processing capacity as of March 31, 2023
TALLAHASSEE, Fla., May 10, 2023 — Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company in the U.S., today announced its results for the quarter ended March 31, 2023. Results are reported in U.S. dollars and in accordance with U.S. Generally Accepted Accounting Principles unless otherwise indicated. Numbers may not sum perfectly due to rounding.
Q1 2023 Financial and Operational Highlights*
Revenue of $289 million, with 95% of revenue from retail sales.
Achieved GAAP gross margin of 52%, with gross profit of $150 million.
SG&A expenses lowered by $24 million sequentially to $102 million.
Reported net loss of $64 million. Adjusted net loss of $21 million* excludes non-recurring charges, asset impairments, disposals and discontinued operations.
Generated adjusted EBITDA of $78 million*, or 27% of revenue.
Cash at quarter end of $195 million.
Opened three new dispensaries in Palatka and Winter Haven, Florida and Beckley, West Virginia.
Launched adult-use sales in Bristol, Connecticut.
First U.S. cannabis company to launch advertising campaigns on Twitter.
Exited the quarter with operations in 11 states, with 32% of retail locations outside of the state of Florida.
READ MORE |
COLUMBIA CARE REPORTS FIRST QUARTER 2023
Quarterly Revenue of $125 Million, an Increase of 1% YoY
Quarterly Gross Profit of Over $47 Million, an Increase of 13% QoQ
Quarterly Adjusted EBITDA1 of Over $16 Million and Adjusted EBITDA Margin1 of Over 13%
NEW YORK–May 15, 2023– Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today reported its financial and operating results for the first quarter ended March 31, 2023. All financial information presented in this release is in U.S. GAAP and in thousands of U.S. dollars, unless otherwise noted.
“As we continue our efforts to move the Cresco Labs transaction forward, we were pleased with the operational progress we made during the first quarter of 2023. Columbia Care continued to optimize our portfolio of assets, and reduce costs to improve profitability as we move towards free cash flow generation later this year. We took steps to proactively manage our capital structure to meet our upcoming maturities and allow for flexibility to reduce leverage going forward. As we’ve seen in recent quarters, the drivers of growth for the Company continue to be east coast markets, especially New Jersey, Virginia and West Virginia, helping us grow our topline revenue 1% over Q1 2022 in spite of economic headwinds. The sequential topline trend reflected the impact of a reduction in the total number of retail locations early in the quarter, the accounting impact from the successful launch of our Stash Cash loyalty program, and expected seasonality, demonstrating the strength of the remaining portfolio,” said Nicholas Vita, CEO of Columbia Care.
READ MORE |
AYR WELLNESS REPORTS FIRST QUARTER 2023 RESULTS
Excluding Discontinued Operations, Revenue up 18% Y/Y to $117.7 Million, up 3% sequentially
Excluding Discontinued Operations, Adjusted EBITDA1 up 64% Y/Y to $26.3 Million, up 9% sequentially (GAAP loss from operations was $21.7 Million, compared to $21.0 Million in Q1/22)
Q1 Ending Cash Balance of $96.5 Million
MIAMI, May 16, 2023 — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), is reporting financial results for the first quarter ended March 31, 2023. Unless otherwise noted, all results are presented in U.S. dollars.
The following financial measures are reported as results from continuing operations due to the sale of the Company’s business in Arizona, which are reported as discontinued operations. All historical comparisons have been restated accordingly.
READ MORE |
AYR WELLNESS REACHES AGREEMENT ON GSD NJ AND SIRA NATURALS EARN-OUT AMENDMENTS AND RETAINS MOELIS & COMPANY LLC AS FINANCIAL ADVISOR
MIAMI, May 12, 2023 — AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announced that it has reached an agreement with Elk Spring Partners, LLC (together with the other selling securityholders under the MIPA (as defined below), the “NJ Counterparties”) to amend the earn-out payment terms under the membership interest purchase agreement (the “MIPA”) dated as of March 26, 2021, as amended, relating to the Company’s acquisition of New Jersey-based GSD NJ, LLC (“GSD”).
The earn-out formula and payment terms under the MIPA were amended as follows:
The first US$10 million portion of the earn-out will continue to be payable in cash, which payment is expected to be made to the NJ Counterparties by May 19, 2023.
The next US$14 million portion of the earn-out, which was to be satisfied by issuing 12.5% promissory notes due September 2024 with interest and principal payments, will instead be satisfied by issuing 13.5% promissory notes due December 2026 with monthly interest-only payments until May 2024 (with 1% monthly amortization thereafter). The promissory notes are expected to be issued by May 19, 2023. This amendment results in a meaningful extension of the maturity date and delays repayment of principal, thereby preserving cash on the balance sheet; and
The remaining portion of the earn-out, which up to a potential maximum amount of US$72.75 million based on sales of GSD, was to be satisfied by issuing subordinate voting shares (“SVS”) based on a 15% discount to the then market price of the SVS, will instead be satisfied by (i) issuing an aggregate of 3,797,468 SVS or shares of CSAC Acquisition NJ Corp. that are exchangeable for SVS at any time or from time to time at the discretion of the holder, at a price equal to US$0.79 per SVS by May 19, 2023; and (ii) a cash payment to the NJ Counterparties of approximately US$10.2 million to be made at a future time based on circumstances related to negotiations with other debtholders. This amendment results in a substantial reduction of dilution to the Company’s shareholders.
READ MORE |
NEW NAME HOUSE OF PLATINUM CANNABIS |
RED WHITE & BLOOM REPORTS FISCAL 2022 RESULTS WITH STRONGER REVENUES AND INCREASED GROSS PROFIT
Annual revenue for fiscal 2022 increasing to $97.5 million, a 260% increase from $37.3 million for fiscal 2021
Gross profit after fair value adjustments for fiscal 2022 of $27.6 million, a $4.4 million increase from gross profit after fair value adjustments for fiscal 2021 of $23.2 million
Year over year decrease in consolidated operating expenses of $2.4 million
A $26.3 million improvement in Adjusted EBITDA loss for fiscal 2022, narrowing to $1.2 million versus $27.5 million Adjusted EBITDA loss for fiscal 2021
TORONTO, May 16, 2023 – Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is pleased to report it has filed its Consolidated Audited Financial Statements (“the Financial Statements”), Management’s Discussion and Analysis (“MD&A”), and associated certifications. The Company has also provided notice to the British Columbia Securities Commission (“BCSC”) of the aforementioned filings to commence the process of lifting the Cease Trade Order (“CTO”) implemented by the BCSC on May 8, 2023. Revocation of the CTO is expected to occur within a few days of today’s filing date.
The Company would like to thank all of its shareholders for their patience while the Company contended with the delays in its reporting associated with the completion of the year-end audit.
The Company will hold its Annual General Meeting (“AGM”) on Friday, June 16, 2023. Further communication will follow for the benefit of shareholders including details on how to access the AGM. We encourage all shareholders to attend the AGM as your participation and input are highly valued.
READ MORE |
FLUENT ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS
Revenue of $77.3 million for Q1 2023
Gross profit (exclusive of depreciation and amortization) of $19.0 million for Q1 2023
Net loss of $31.9 million for Q1 2023
Media margin of $22.0 million for Q1 2023
Adjusted EBITDA of $0.4 million for Q1 2023
Adjusted net loss of $2.7 million for Q1 2023
NEW YORK, May 15, 2023 — Fluent, Inc. (NASDAQ: FLNT), a leading data-driven performance marketing company, today reported financial results for the first quarter ended March 31, 2023.
Don Patrick, Fluent’s Chief Executive Officer, commented, “Our first quarter results came in as expected and continue to reinforce the imperative behind ‘Quality as our North Star,’ while also reflecting the current macroeconomic headwinds in the digital advertising industry. Our foundational commitment to enhance the quality of consumer engagement within our Performance Marketplace, represents the strategic infrastructure that will facilitate our future growth while enhancing Fluent brand equity – both with consumers and our clients. This is our definitive strategic course that will ultimately create greater shareholder value for our investors.
READ MORE |
FLUENT MOVES U.S. HEADQUARTERS TO TAMPA, FLORIDA
AMPA, Fla., May 16, 2023 – Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) (“FLUENT” or the “Company“), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, announced it is moving its headquarters from Miami to the Westshore District of Tampa, Florida. Over the next four months, the Company plans to create more than 30 new jobs in administration, finance, human resources, marketing, sales, operations and other key roles, with an average salary of $100K.
“We’re extremely grateful to the Tampa Bay Economic Development Council (“EDC”) and the Tampa community as a whole for welcoming us with open arms,” said FLUENT CEO Robert Beasley. “Our ultimate goal with this relocation is to connect the brain with the heart of the Company and centralize our workforce. Tampa is already a major hub for our cultivation and production facilities, and we continue to be impressed with the city’s large talent pool, business-friendly policies and overall quality of life. We believe our relocation is not only the best decision for our employees and culture, but a smart, fiscally responsible decision for the Company’s shareholders. We look forward to providing good-paying jobs to the Tampa community as FLUENT further scales its operations in Florida.”
READ MORE |
VERANO ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS
Company Capitalizes on Strength of Recently-Converted Adult Use Markets to Deliver Revenue of $227 Million, a 12% Year-Over-Year Increase
CHICAGO, May 10, 2023 — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the first quarter ended March 31, 2023, which were prepared in accordance with U.S. Generally Accepted Accounting Principles (“U.S. GAAP”).
Management Commentary
“I’m very pleased with our first quarter results which validate the effectiveness of our strategy, highlighted by revenue growth, positive Free Cash Flow1 and strong Adjusted EBITDA2 margins,” said George Archos, Verano Founder, Chairman and Chief Executive Officer. “Our results were bolstered by the launch of adult use sales in Connecticut, expanding our retail footprint across key markets, strengthening our portfolio to satisfy consumers’ evolving preferences, and delivering greater efficiencies that increased output across many key metrics. We remain confident in our ability to continue growing the business in a challenged environment, will closely monitor developments in Washington D.C. on the reintroduction of SAFE banking legislation, and look forward to leveraging our deep experience in transitioning markets as we approach the forthcoming launch of adult use sales in Maryland.”
READ MORE |
IANTHUS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
NEW YORK and TORONTO, May 15, 2023 – iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN) (OTCPK: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, today reported its financial results for the first quarter ended March 31, 2023. The Company’s Quarterly Report on Form 10-Q, which includes its unaudited interim condensed consolidated financial statements for the three months ended March 31, 2023 and the related management’s discussion and analysis of financial condition and results of operations, can be accessed on the Securities and Exchange Commission’s (“SEC’s”) website at www.sec.gov, the Company’s SEDAR profile at www.sedar.com, and on the Company’s website at www.iAnthus.com. The Company’s financial statements are reported in accordance with U.S. generally accepted accounting principles (“GAAP”). All currency is expressed in U.S. dollars.
First Quarter 2023 Financial Highlights
Revenue of $36.8 million, a sequential decrease of 2.2% from Q4 2022 and a decrease of 14.1% from the same quarter in the prior year.
Gross profit of $15.5 million, a sequential decrease of 3.6% from Q4 2022 and a decrease of 31.0% from the same quarter in the prior year.
Gross margin of 42.2%, relatively flat when compared to Q4 2022 and a decrease of 1036bps from the same quarter in the prior year.
Net loss of $18.6 million, or a net loss of $0.00 per share, compared to a net loss of $43.7 million or a net loss of $0.01 per share in Q4 2022, and compared to a net loss of $10.1 million, or a net loss of $0.06 per share, in the same quarter in the prior year.
Adjusted EBITDA(6) of $0.9 million, a sequential increase from ($1.0) million in Q4 2022 and a decrease from $3.4 million from the same quarter in the prior year.
READ MORE |
PLANET 13 ANNOUNCES Q1 2023 FINANCIAL RESULTS
Q1 2023 Revenue of $24.9 million, compared to $24.8 million in Q4 2022
Q1 2023 Net loss of $6.3 million
Q1 2023 Adjusted EBITDA of $0.68 million
All figures are reported in United States dollars ($) unless otherwise indicated
LAS VEGAS, NV May 15, 2023 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQB:PLNHF) (“Planet 13” or the “Company“), a leading vertically-integrated multi-state cannabis company, today announced its financial results for the three-month ended March 31, 2023. Planet 13’s financial statements are prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”).
“Planet 13 started the year with consistent results notwithstanding overall economic conditions. In Q1 we saw a stabilization in cannabis prices resulting in an improvement in our retail revenue from the SuperStore. In Nevada, we maintained our share of sales above 8%, consistent with our long-term goals. We also saw strong sequential growth in wholesale as we continued to add more accounts and increase sales and productivity with our existing buyers. In California, growth in our wholesale business offset some of the seasonal decline in retail sales,” said Larry Scheffler, Co-CEO of Planet 13.
READ MORE |
NATIONAL AND INTERNATIONAL NEWS |
JUSHI HOLDINGS INC. REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
Total Revenue of $69.9 Million, an increase of 12.9% YoY
Net Loss of $12.4 Million, an improvement of 37.0% YoY
Adjusted EBITDA of $7.6 Million, an improvement of $8.5 Million YoY
Continued Financial and Operational Improvements at our Grower-Processor Operations
Added Ohio as Fifth Vertically Integrated Market
BOCA RATON, Fla., May 12, 2023 — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, is pleased to announce its financial results for the first quarter ended March 31, 2023 (“Q1 2023”). All financial information is unaudited and provided in U.S. dollars unless otherwise indicated and is prepared under U.S. Generally Accepted Accounting Principles (“GAAP”).
First Quarter 2023 Financial Highlights1
Total revenue of $69.9 million, an increase of 12.9% year-over-year
Gross profit margin was 42.9% of revenue, compared to 30.9% in Q1 2022 and 28.6% in Q4 2022
Net loss of $12.4 million, an improvement of $7.3 million year-over-year
Adjusted EBITDA1 of $7.6 million, an improvement of $8.5 million year-over-year and $1.6 million sequentially
Cash, cash equivalents, and restricted cash of $19.4 million as of quarter end
1 See “Use of Non-GAAP Financial Information” and “Unaudited Reconciliation of Net (Loss) Income to Adjusted EBITDA” below.
READ MORE |
DELTA 9 REPORTS FIRST QUARTER 2023 RESULTS
WINNIPEG, Manitoba, May 15, 2023 — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQB: DLTNF) (“Delta 9” or the “Company”), is pleased to announce financial and operating results for the three-month period ending March 31, 2023.
Financial Highlights for Q1, 2023:
Net revenue of $16.9 million versus $12.5 million for the three-month period ending March 31, 2022, an increase of 35%.
Gross profit, before changes in the fair value of biological assets, of $4.2 million versus $3.0 million for the three-month period ending March 31, 2022, an increase of 42%.
Net income (loss) from operations of $(1.2) million versus $(2.9) million for the three-month period ending March 31, 2022.
Adjusted EBITDA (loss) was $(475,595) versus Adjusted EBITDA loss of $(1.7) million for the three-month period ending March 31, 2022.
Cash used in operations was $89,530 versus cash used in operations of $2.5 million for the three-month period ending March 31, 2022.
READ MORE |
TREEZ ENTERS NEW JERSEY CANNABIS MARKET WITH SILVERLEAF DISPENSARY
TREEZ WILL SERVE AS THE EXCLUSIVE RETAIL TECHNOLOGY AND DATA PROVIDER FOR SILVERLEAF DISPENSARY IN NEW JERSEY
SAN FRANCISCO, May 16, 2023 — Treez, the leading enterprise commerce technology platform that streamlines retail operations within the cannabis industry, today announced its first official go-live implementation in the New Jersey market with SilverLeaf, Central Jersey’s Premier Medical Cannabis Dispensary.
“New Jersey is an exciting market for Treez to enter; the burgeoning industry brings forth the opportunity to grow with our partnered retailers and the communities we reside in,” said John Yang, CEO of Treez. “We look forward to growing with SilverLeaf as their preferred retail technology provider and are excited to show SilverLeaf and the New Jersey market the capabilities of Treez’s data-centric point of sale and open API platform.”
READ MORE |
HEMPSANA HOLDINGS LTD. (THE “CORPORATION” OR “HEMPSANA”) ANNOUNCES $900,000.00 CONVERTIBLE UNSECURED DEBENTURE FINANCING
TORONTO, May 11, 2023 — Hempsana (CSE: HMPS) announced today that it has entered into a Convertible Debt Purchase Agreement (the “Agreement”) with Antosh Consulting Inc. (the “Lender”) to borrow an aggregate principal amount of $900,000 pursuant to an unsecured convertible debenture (the “Debenture”), by way of a private placement exemption from the prospectus requirement. The Debenture will accrue interest rate at the rate of 8.0% per annum and has a maturity date of five years from the date of issue, unless converted earlier in accordance with its terms.
The principal amount of the Debenture will automatically convert into Common Shares of the Corporation in the event that the Common Shares trade at a volume-weighted average trading price of $0.25 per share for a period of 10 consecutive trading days on the Canadian Securities Exchange. The Debenture will convert into Common Shares at a conversion price of $0.05 per share. The Debenture may also be converted into Common Shares at such conversion price at the option of the Lender, at any time after the maturity date. The terms of the Agreement also provide that the Lender will be issued 12,000,000 Common Shares at $0.05 per share as consideration for the issuance of the Debenture.
READ MORE |
LOWELL FARMS INC. ANNOUNCES UNAUDITED FIRST QUARTER 2023 FINANCIAL AND OPERATIONAL RESULTS
SALINAS, Calif., May 11, 2023 — Lowell Farms Inc. (“Lowell Farms” or the “Company”) (CSE: LOWL; OTCQX: LOWLF), a California-born vertically integrated cannabis company with advanced production capabilities including cultivation, extraction, manufacturing, and distribution, announces unaudited revenue and operating results for the first quarter of 2023 (ended March 31, 2023). All figures stated are in US Dollars.
First Quarter Financial Highlights
Revenues:
Net revenue generated for Q1 2023 decreased 39% to $7.5 million, as compared to $12.4 million for Q1 2022. Net revenue was $9.3 million for Q4 2022, a decrease of 19%.
CPG revenue decreased 49% compared to Q1 2022, and decreased 18% compared to Q4 2022.
Bulk revenue from self-grown wholesale products increased 44% compared to Q1 2022 and decreased 9% compared to Q4 2022. In Q1 2023, there was a 31% decrease in volume and a 24% increase in realized price per lb compared to Q4 2022.
LFS revenue decreased 86% compared to Q1 2022 and decreased 79% compared to Q4 2022.
Out of state licensing revenue decreased 69% compared to Q1 2022 and decreased 23% compared to Q4 2022.
READ MORE |
UNRIVALED BRANDS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
COMPANY REPORTS SECOND CONSECUTIVE QUARTER OF NET INCOME AND POSITIVE EBITDA
SANTA ANA, Calif., May 11, 2023 — Unrivaled Brands, Inc. (OTCQB: UNRV) (“Unrivaled” or the “Company”), a cannabis company with operations throughout California, today reported financial results for its fiscal first quarter ended March 31, 2023.
First Quarter 2023 Highlights
Revenue for the quarter ended March 31, 2023 remained consistent with the prior quarter at $8.7 million. Revenue for the quarter ended March 31, 2023 was driven by our four retail stores and sales of our in-house cultivated flower and Korova-branded products.
While revenues for the quarter ended March 31, 2023 remained consistent quarter-over-quarter, gross margin increased to 48% for the quarter ended March 31, 2023 as compared to 44% during the prior quarter ended December 31, 2022, and up from 31% from the quarter ended March 31, 2022.
Net income from continuing operations for the quarter ended March 31, 2023 was $0.4 million compared to previous quarter of $3.9 million.
EBITDA from continuing operations for the quarter ended March 31, 2023 was $2.9 million compared to previous quarter of $9.7 million.
For the quarter ended March 31, 2023, the Company had a $3.0 million gain on extinguishment of debt and a $1.5 million gain on settlement of liabilities. The Company also had $1.0 million of interest expense and $1.4 million of non-cash expense for income taxes, depreciation, and amortization.
In February 2023, the Company held a grand re-opening for its Blüm San Leandro store and revenues continue to grow as we reconnect with customers.
READ MORE |
SOLEI BRAND DEBUTS PREMIUM CBD, CBN AND THC INFUSED TEA COLLECTION
SOLEI’S FIRST WELLNESS-FOCUSED TEA COLLECTION INCLUDES PEACH GINGER, LAVENDER CHAMOMILE, AND MINT, PERFECTLY FORMULATED FOR #ELEVATIONONYOURTERMS
TORONTO, May 11, 2023 — Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today premiered a new infused tea collection by cannabis wellness brand, Solei, marking the brand’s first cannabis infused drink line.
Solei’s new tea collection is a wellness-based product line of caffeine-free teas produced with natural ingredients including cane sugar, premium whole-leaf herbal tea, and tasteful aromatic blends of Peach Ginger, Lavender Chamomile, and Mint, featuring an infusion of unique CBD, CBN, and THC formulations to optimize personal self-care routines. Each premium tea blend is micro-dosed for ease of consumption and is ready to steep however desired – hot or cold, sweetened, or unsweetened, and even as a base to tea inspired mocktails.
Solei Peach Ginger Green Tea is a CBD infused premium whole-leaf tea blend that brings together sweet notes of peach and a zesty kick of ginger that leaves you with an exceptionally well-balanced taste. Each pack contains five biodegradable pyramid tea bag sachets, each infused with 20 mg of CBD and <1mg THC. Now Available in Alberta, Manitoba, Quebec, and Ontario in 5 x 3g packs.
Solei Lavender Chamomile Tea is a CBD and CBN infused tea with a gentle blend of soothing chamomile flowers, warming lemongrass, and a delicate floral aroma of lavender. A cup of Solei’s Lavender Chamomile tea is a beautiful light golden colour when brewed. Each pack contains five biodegradable pyramid tea bag sachets, each infused with 20 mg of CBD, 10mg CBN and <1mg THC. Now Available in British Columbia, Alberta, Manitoba, Quebec, and Ontario in 5 x 5g pack
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND
DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS OVER 816,000 AND 565 DISPENSING LOCATIONS |
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
MAY 12, 2023 Report BY THE NUMBERS Qualified Patients: (Active ID Card): MAY 12 2023- 816,944 MAY 05 2023- 814,965
APR 28 2023- 812,944 APR 21 2023- 810,675 APR 14 2023- 807,438
Patients Last Week: 1,979 Qualified Ordering Physicians: 2,441 New Doctors Last Week: 14 Reporting Period: MAY 5 TO MAY 112023
Amount of Medical Marijuana Dispensed - (mgs THC) 302,599,412 Amount of Low-THC Cannabis Dispensed - (mgs CBD) 3,492,988 Amount of Marijuana in a From for Smoking (oz) 104,814.539 Approved Dispensing Locations: 565 ADD LAST WEEK +1
THE FLOWERY - OCALA |
UPCOMING MEETING AND CONFERENCES |
THE FLORIDA MEDICAL CANNABIS PHYSICIANS GROUP ANNUAL IN-PERSON MEETING WILL BE HELD
AT THE FLORIDA MEDICAL CANNABIS CONFERENCE & EXHIBITION SEE INFORMATION BELOW FOR REGISTRATION |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|